66746 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Vickers
    Vickers
  4. Ladanyi
    Ladanyi
  5. Scher
    Scher
  6. Motzer
    Motzer
  7. Reuter
    Reuter
  8. Jarnagin
    Jarnagin
  9. Fong
    Fong
  10. Antonescu
    Antonescu

Groups

  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)
  7. Sloan Kettering Institute Postdocs (7820)
  8. Population Sciences Research Program (7144)
  9. Department of Pathology and Laboratory Medicine (6438)
  10. Epidemiology and Biostatistics (6429)
  1. "Journal article"
Formats
  1. Journal Article (66746)
Groups
  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)

More Groups

People
  1. Murray Brennan (769)
  2. Mithat Gonen (757)
  3. Andrew Vickers (683)
  4. Marc Ladanyi (647)
  5. Howard Scher (624)
  6. Robert Motzer (609)

More People

Years
  1. 2025 (1026)
  2. 2024 (2329)
  3. 2023 (2318)
  4. 2022 (2449)
  5. 2021 (2507)
  6. 2020 (2337)

More Years

Publications
  1. Journal of Clinical Oncology (2143)
  2. Cancer (1294)
  3. Clinical Cancer Research (1174)
  4. Proceedings of the National Academy of Sciences of the United States of America (985)
  5. Blood (938)
  6. Annals of Surgical Oncology (885)

More Publications

Publishers
  1. Elsevier Inc. (7387)
  2. Springer (4153)
  3. Elsevier Science, Inc. (3901)
  4. Lippincott Williams & Wilkins (3828)
  5. Nature Publishing Group (3746)
  6. Wiley Blackwell (3486)

More Publishers

Results (66746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: Results from the phase II KEYNOTE-158 study
    Journal Article

    Marabelle, A.; Le, D. T.; Ascierto, P. A.; Di Giacomo, A. M.; De Jesus-Acosta, A.; Delord, J. P.; Geva, R.; Gottfried, M.; Penel, N.; Hansen, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: An NRG Oncology Group study
    Journal Article

    Chase, D.; Huang, H. Q.; Monk, B. J.; Ramondetta, L. M.; Penson, R. T.; Gil, K.; Landrum, L. M.; Leitao, M.; Oaknin, A.; Huh, W. K.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
    Journal Article

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; O'Cearbhaill, R.; Aghajanian, C. A.; Schilder, R.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer
    Journal Article

    Schoenfeld, A. J.; Chan, J. M.; Kubota, D.; Sato, H.; Rizvi, H.; Daneshbod, Y.; Chang, J. C.; Paik, P. K.; Offin, M.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: Analysis from the phase II TRITON2 study
    Journal Article

    Abida, W.; Campbell, D.; Patnaik, A.; Shapiro, J. D.; Sautois, B.; Vogelzang, N. J.; Voog, E. G.; Bryce, A. H.; McDermott, R.; Ricci, F.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • The evolutionary origins of recurrent pancreatic cancer
    Journal Article

    Sakamoto, H.; Attiyeh, M. A.; Gerold, J. M.; Makohon-Moore, A. P.; Hayashi, A.; Hong, J.; Kappagantula, R.; Zhang, L.; Melchor, J. P.; Reiter, J. G.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT
    Journal Article

    Hill, J. A.; Nichols, W. G.; Marty, F. M.; Papanicolaou, G. A.; Brundage, T. M.; Lanier, R.; Zerr, D. M.; Boeckh, M. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): A multicenter, open-label phase 2 trial
    Journal Article

    Jagasia, M.; Perales, M. A.; Schroeder, M. A.; Ali, H.; Shah, N. N.; Chen, Y. B.; Fazal, S.; Dawkins, F. W.; Arbushites, M. C.; Tian, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): A multicenter matched cohort analysis
    Journal Article

    Kheterpal, S.; Vaughn, M. T.; Dubovoy, T. Z.; Shah, N. J.; Bash, L. D.; Colquhoun, D. A.; Shanks, A. M.; Mathis, M. R.; Soto, R. G.; Bardia, A.; more...
    Anesthesiology (2020)

    Fulltext@MSK | Save
  • BCOR expression in Mullerian adenosarcoma: A potential diagnostic pitfall
    Journal Article

    Muthukumarana, V.; Fix, D. J.; Stolnicu, S.; Park, K. J.; Soslow, R. A.; Benayed, R.; Ladanyi, M.; Antonescu, C. R.; Chiang, S.
    American Journal of Surgical Pathology (2020)

    Fulltext@MSK | Save